Systematic dose-extension of octreotide LAR: the importance of individual tailoring of treatment in patients with acromegaly.

Systematic dose-extension of octreotide LAR: the importance of individual tailoring of treatment in patients with acromegaly.

OBJECTIVE: The depot long-acting somatostatin analogue octreotide LAR (LAR) provides effective and well-tolerated treatment for acromegaly. Despite a 4-weekly recommended injection frequency, prolonged duration of GH suppression has been observed in some patients following treatment with long-actin...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak:	Turner, H, Thornton-Jones, V, Wass, J
Formatua:	Journal article
Hizkuntza:	English
Argitaratua:	2004

Antzeko izenburuak

A comparison of lanreotide and octreotide LAR for treatment of acromegaly.
nork: Turner, H, et al.
Argitaratua: (1999)

Differing effects on gall-bladder motility of lanreotide SR and octreotide LAR for treatment of acromegaly.
nork: Turner, H, et al.
Argitaratua: (1999)

Discontinuation of octreotide LAR after long term, successful treatment of patients with acromegaly: is it worth trying?
nork: Ramírez, C, et al.
Argitaratua: (2012)

EVEROLIMUS PLUS OCTREOTIDE LAR IN PATIENTS WITH LUNG CARCINOIDS
nork: Granberg, D, et al.
Argitaratua: (2014)

The value of an acute octreotide suppression test in predicting long-term responses to depot somatostatin analogues in patients with active acromegaly.
nork: Karavitaki, N, et al.
Argitaratua: (2005)

New treatments for acromegaly.
nork: Wass, J, et al.
Argitaratua: (1998)

Acromegaly: Treatment with somatostatin analogs
nork: Karavitaki, N, et al.
Argitaratua: (2005)

Evidence for the effectiveness of radiotherapy in the treatment of acromegaly.
nork: Wass, J
Argitaratua: (1997)

Effect of Everolimus plus Octreotide LAR in Patients With Advanced Lung Neuroendocrine Tumours - Analysis From RADIANT-2
nork: Fazio, N, et al.
Argitaratua: (2011)

Acute octreotide suppression test (100 mu g sc): a valuable tool for predicting the long-term response to the long-acting somatostatin analogs in patients with active acromegaly
nork: Karavitaki, N, et al.
Argitaratua: (2005)

DEPOT BROMOCRIPTINE IN THE TREATMENT OF PROLACTINOMAS AND ACROMEGALY
nork: Grossman, A, et al.
Argitaratua: (1985)

Depot-bromocriptine treatment for prolactinomas and acromegaly.
nork: Grossman, A, et al.
Argitaratua: (1986)

Pegvisomant: a new treatment modality for acromegaly.
nork: Karavitaki, N, et al.
Argitaratua: (2004)

Long-term effects of radiotherapy for acromegaly.
nork: Wass, J
Argitaratua: (1996)

Radiotherapy in acromegaly: a protagonists viewpoint.
nork: Wass, J
Argitaratua: (2003)

Dynamic testing in the diagnosis and follow-up of patients with acromegaly.
nork: Wass, J
Argitaratua: (2003)

Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size.
nork: Bevan, J, et al.
Argitaratua: (2002)

Investigation protocol: acromegaly and its investigation.
nork: Duncan, E, et al.
Argitaratua: (1999)

A single-center open-label study to investigate the efficacy and safety of repeated subcutaneous injections of lanreotide Autogel in patients with acromegaly previously treated with octreotide.
nork: Kelly, P, et al.
Argitaratua: (2010)

Hypercalcaemia in acromegaly is not always due to men-1
nork: Zabuliene, L, et al.
Argitaratua: (2005)

Acromegaly, colonic polyps and carcinoma.
nork: Jenkins, P, et al.
Argitaratua: (1997)

Guidelines for acromegaly management.
nork: Melmed, S, et al.
Argitaratua: (2002)

The pathology of median neuropathy in acromegaly.
nork: Jenkins, P, et al.
Argitaratua: (2000)

Reduction of elevated IGF-1 levels in coincident amyotrophic lateral sclerosis and acromegaly.
nork: Pereira, E, et al.
Argitaratua: (2010)

Acromegaly and anaplastic astrocytoma: coincidence or pathophysiological relation?
nork: Fernandez, A, et al.
Argitaratua: (2008)

LAr1-ND: Testing Neutrino Anomalies with Multiple LArTPC Detectors at Fermilab
nork: Adams, C, et al.
Argitaratua: (2013)

Criteria for cure of acromegaly: a consensus statement.
nork: Giustina, A, et al.
Argitaratua: (2000)

Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide.
nork: Karavitaki, N, et al.
Argitaratua: (2008)

Acromegaly: Beyond surgery.
nork: Thanabalasingham, G, et al.
Argitaratua: (2013)

Acromegaly or chronic renal failure: a diagnostic dilemma.
nork: Wong, N, et al.
Argitaratua: (1997)

Chemical Composition And Digestibility Of Natural And Domestic Food Of The Lar Gibbon (Hylobates Lar) In Malaysia
nork: Subramaniam, Vellayan
Argitaratua: (1981)

Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience.
nork: Ahmed, S, et al.
Argitaratua: (1999)

90Y-edotreotide for metastatic carcinoid refractory to octreotide.
nork: Bushnell, D, et al.
Argitaratua: (2010)

Growth hormone, insulin-like growth factor-I and its binding proteins in the follow-up of acromegaly.
nork: Wass, J
Argitaratua: (1997)

Pituitary imaging using a labelled somatostatin analogue in acromegaly.
nork: Ur, E, et al.
Argitaratua: (1992)

Somatostatin Analogue Treatment Increases AIP Protein Expression in Somatotroph Tumours from Patients with Acromegaly and in GH3 Cells in vitro.
nork: Chahal, H, et al.
Argitaratua: (2011)

Uterine leiomyomata in women with acromegaly
nork: Kaltsas, G, et al.
Argitaratua: (2000)

Guidelines for acromegaly management: an update.
nork: Melmed, S, et al.
Argitaratua: (2009)

Menstrual irregularity in women with acromegaly.
nork: Kaltsas, G, et al.
Argitaratua: (1999)

KAWASAN LAR DI KABUPATEN SUMBAWA
nork: , HILAL, et al.
Argitaratua: (2013)